•] Shares ADAGIO THERAPEUTICS, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • August 2nd, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 2nd, 2021 Company Industry Jurisdiction
ADAGIO THERAPEUTICS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • August 2nd, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 2nd, 2021 Company Industry JurisdictionThis Indemnification Agreement (this “Agreement”) is dated as of , 20 , and is between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 2nd, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 2nd, 2021 Company Industry JurisdictionThis Amended and Restated Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and Lynn Connolly (the “Executive”), this [___] day of [_______] 2021. This Agreement amends, restates, and supersedes in its entirety that certain Employment Agreement, dated November 9, 2020 (the “Prior Agreement”), between the Executive and the Company.